{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:45:45Z","timestamp":1792788345644,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum W\u00fcrzburg","id":[{"id":"https:\/\/ror.org\/03pvr2g57","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Allergy Asthma Clin Immunol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Basophils are recognized as important effector cells during the sensitization and effector phases of IgE-mediated allergy. Besides histamine release during anaphylaxis, basophils contribute to early immune polarization as an important source of Th2-associated cytokines.\n                      <jats:italic>Vespula<\/jats:italic>\n                      spp. venom immunotherapy (VIT) represents a prime example of clinically highly effective allergen-specific immunotherapy. This study investigated functional and phenotypic changes in circulating basophils during early VIT in a homogenous case series.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Twenty-four patients eligible for VIT were examined before treatment, after 3 days, and after 1 month of therapy. Basophils were primed with interleukin-(IL-)3 and stimulated with IgE-dependent triggers, including\n                      <jats:italic>Vespula<\/jats:italic>\n                      spp. venom and an anti-IgE antibody, as well as the IgE-independent bacterial peptide N-formylmethionyl-leucyl-phenylalanine (fMLP). Basophil activation was assessed by flow cytometric measurement of CD63 expression. In parallel, Fc\n                      <jats:sub>\u03b5<\/jats:sub>\n                      RI and Fc\n                      <jats:sub>\u03b3<\/jats:sub>\n                      RIIb receptor expression on basophils was quantified, and serum levels of total IgE,\n                      <jats:italic>Vespula<\/jats:italic>\n                      spp. venom-specific IgE, and venom-specific IgG\n                      <jats:sub>4<\/jats:sub>\n                      were measured. Changes over time were tested using a mixed-effects model for repeated measures. Paired t-tests, Wilcoxon signed-rank tests, and Friedman tests were used for paired comparisons and non-parametric repeated measures.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      After one month of VIT, venom-specific basophil excitability was significantly reduced. In contrast, activation by anti-IgE and fMLP remained largely unchanged. An increase of both Fc\n                      <jats:sub>\u03b5<\/jats:sub>\n                      RI and Fc\n                      <jats:sub>\u03b3<\/jats:sub>\n                      RIIb expression on basophils was already detectable at day 3 after starting VIT and reached statistical significance at day 28. Serologically, total IgE and\n                      <jats:italic>Vespula<\/jats:italic>\n                      spp. venom-specific IgE slightly rose during VIT, but the most pronounced increase was observed for venom-specific IgG\n                      <jats:sub>4<\/jats:sub>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Data of this study suggest that upregulation of Fc\n                      <jats:sub>\u03b3<\/jats:sub>\n                      RIIb together with venom-specific IgG\n                      <jats:sub>4<\/jats:sub>\n                      induction drives venom-specific basophil suppression, possibly by Fc\n                      <jats:sub>\u03b3<\/jats:sub>\n                      RIIb-Fc\n                      <jats:sub>\u03b5<\/jats:sub>\n                      RI co-aggregation. The overall picture of venom-specific basophil activation, basophil Fc\n                      <jats:sub>\u03b3<\/jats:sub>\n                      RIIb expression, and serum IgG\n                      <jats:sub>4<\/jats:sub>\n                      may serve as a biomarker of immune modulation towards tolerance.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13223-026-01062-w","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:46:06Z","timestamp":1790246766000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vespula spp. venom immunotherapy: basophil excitability and Fc\u03b5RI\/Fc\u03b3RIIb expression"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1435-0245","authenticated-orcid":false,"given":"Janik","family":"Fleissner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Stoevesandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Goebeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Trautmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kerstan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"issue":"4","key":"1062_CR1","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/all.13262","volume":"73","author":"GJ Sturm","year":"2018","unstructured":"Sturm GJ, Varga EM, Roberts G, Mosbech H, Bil\u00f2 MB, Akdis CA, et al. EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy. Allergy. 2018;73(4):744\u201364.","journal-title":"Allergy"},{"issue":"3","key":"1062_CR2","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.jaci.2016.12.989","volume":"140","author":"P Koro\u0161ec","year":"2017","unstructured":"Koro\u0161ec P, Turner PJ, \u0160ilar M, Kopa\u010d P, Ko\u0161nik M, Gibbs BF, et al. Basophils, high-affinity IgE receptors, and CCL2 in human anaphylaxis. J Allergy Clin Immunol. 2017;140(3):750\u2013e815.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"1062_CR3","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1182\/blood.V10.5.467.467","volume":"10","author":"HT Graham","year":"1955","unstructured":"Graham HT, Lowry OH, Wheelwright F, Lenz MA, Parish HH. Distribution of histamine among leukocytes and platelets. Blood. 1955;10(5):467\u201381.","journal-title":"Blood"},{"issue":"4","key":"1062_CR4","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1172\/JCI114557","volume":"85","author":"HL Thompson","year":"1990","unstructured":"Thompson HL, Metcalfe DD, Kinet JP. Early expression of high-affinity receptor for immunoglobulin E (Fc epsilon RI) during differentiation of mouse mast cells and human basophils. J Clin Invest. 1990;85(4):1227\u201333.","journal-title":"J Clin Invest"},{"issue":"5","key":"1062_CR5","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.4049\/jimmunol.0802870","volume":"182","author":"K Ohmori","year":"2009","unstructured":"Ohmori K, Luo Y, Jia Y, Nishida J, Wang Z, Bunting KD, et al. IL-3 induces basophil expansion in vivo by directing granulocyte-monocyte progenitors to differentiate into basophil lineage-restricted progenitors in the bone marrow and by increasing the number of basophil\/mast cell progenitors in the spleen. J Immunol. 2009;182(5):2835\u201341.","journal-title":"J Immunol"},{"issue":"1","key":"1062_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.immuni.2013.06.012","volume":"39","author":"X Qi","year":"2013","unstructured":"Qi X, Hong J, Chaves L, Zhuang Y, Chen Y, Wang D, et al. Antagonistic regulation by the transcription factors C\/EBPalpha and MITF specifies basophil and mast cell fates. Immunity. 2013;39(1):97\u2013110.","journal-title":"Immunity"},{"issue":"4","key":"1062_CR7","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/imm.13754","volume":"171","author":"L Mansouri","year":"2024","unstructured":"Mansouri L, Kalm F, Bj\u00f6rkander S, Mel\u00e9n E, Lundahl J, Nopp A. Sequential engagement of adhesion molecules and cytokine receptors impacts both piecemeal and anaphylactic degranulation of human basophils. Immunology. 2024;171(4):609\u201317.","journal-title":"Immunology"},{"issue":"9","key":"1062_CR8","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1111\/j.1365-2222.2012.04030.x","volume":"42","author":"J Eckl-Dorna","year":"2012","unstructured":"Eckl-Dorna J, Pree I, Reisinger J, Marth K, Chen KW, Vrtala S, et al. The majority of allergen-specific IgE in the blood of allergic patients does not originate from blood-derived B cells or plasma cells. Clin Exp Allergy. 2012;42(9):1347\u201355.","journal-title":"Clin Exp Allergy"},{"issue":"7","key":"1062_CR9","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/ni.1738","volume":"10","author":"CL Sokol","year":"2009","unstructured":"Sokol CL, Chu NQ, Yu S, Nish SA, Laufer TM, Medzhitov R. Basophils function as antigen-presenting cells for an allergen-induced T helper type 2 response. Nat Immunol. 2009;10(7):713\u201320.","journal-title":"Nat Immunol"},{"key":"1062_CR10","doi-asserted-by":"crossref","unstructured":"Dem\u0161ar Luzar A, Koro\u0161ec P, Ko\u0161nik M, Zidarn M, Rijavec M. Hymenoptera venom immunotherapy: immune mechanisms of induced protection and tolerance. Cells. 2021;10(7).","DOI":"10.3390\/cells10071575"},{"issue":"12","key":"1062_CR11","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1111\/all.12044","volume":"67","author":"N \u010celesnik","year":"2012","unstructured":"\u010celesnik N, Vesel T, Rijavec M, \u0160ilar M, Er\u017een R, Ko\u0161nik M, et al. Short-term venom immunotherapy induces desensitization of FcepsilonRI-mediated basophil response. Allergy. 2012;67(12):1594\u2013600.","journal-title":"Allergy"},{"issue":"6","key":"1062_CR12","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1111\/j.1398-9995.2012.02817.x","volume":"67","author":"R Er\u017een","year":"2012","unstructured":"Er\u017een R, Ko\u0161nik M, \u0160ilar M, Koro\u0161ec P. Basophil response and the induction of a tolerance in venom immunotherapy: a long-term sting challenge study. Allergy. 2012;67(6):822\u201330.","journal-title":"Allergy"},{"issue":"2","key":"1062_CR13","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.jaci.2010.11.025","volume":"127","author":"A Kerstan","year":"2011","unstructured":"Kerstan A, Albert C, Klein D, Br\u00f6cker EB, Trautmann A. Wasp venom immunotherapy induces activation and homing of CD4(+)CD25(+) forkhead box protein 3-positive regulatory T cells controlling T(H)1 responses. J Allergy Clin Immunol. 2011;127(2):495\u2013501. e1-6.","journal-title":"J Allergy Clin Immunol"},{"issue":"8009","key":"1062_CR14","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/S0140-6736(77)91953-5","volume":"1","author":"J Ring","year":"1977","unstructured":"Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet. 1977;1(8009):466\u20139.","journal-title":"Lancet"},{"issue":"6","key":"1062_CR15","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.4049\/jimmunol.158.6.2517","volume":"158","author":"CS Lantz","year":"1997","unstructured":"Lantz CS, Yamaguchi M, Oettgen HC, Katona IM, Miyajima I, Kinet JP, et al. IgE regulates mouse basophil Fc epsilon RI expression in vivo. J Immunol. 1997;158(6):2517\u201321.","journal-title":"J Immunol"},{"issue":"3","key":"1062_CR16","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.4049\/jimmunol.1601334","volume":"198","author":"A Mahajan","year":"2017","unstructured":"Mahajan A, Youssef LA, Cleyrat C, Grattan R, Lucero SR, Mattison CP, et al. Allergen valency, dose, and fcepsilonri occupancy set thresholds for secretory responses to pen a 1 and motivate design of hypoallergens. J Immunol. 2017;198(3):1034\u201346.","journal-title":"J Immunol"},{"key":"1062_CR17","doi-asserted-by":"crossref","unstructured":"Puxkandl V, Aigner S, Burner T, Lackner A, Mo\u00f1ino-Romero S, Kimeswenger S et al. Rapid change in fcepsilon RI occupancy on basophils after venom immunotherapy induction. Int J Mol Sci. 2025;26(15).","DOI":"10.3390\/ijms26157511"},{"issue":"4","key":"1062_CR18","doi-asserted-by":"publisher","first-page":"e94762","DOI":"10.1371\/journal.pone.0094762","volume":"9","author":"N \u010celesnik Smodi\u0161","year":"2014","unstructured":"\u010celesnik Smodi\u0161 N, \u0160ilar M, Er\u017een R, Rijavec M, Ko\u0161nik M, Koro\u0161ec P. Down-regulation of FcepsilonRI-mediated CD63 basophil response during short-term VIT determined venom-nonspecific desensitization. PLoS ONE. 2014;9(4):e94762.","journal-title":"PLoS ONE"},{"issue":"5","key":"1062_CR19","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41419-018-0526-9","volume":"9","author":"F Zellweger","year":"2018","unstructured":"Zellweger F, Buschor P, Hobi G, Brigger D, Dahinden CA, Villiger PM, et al. IL-3 but not monomeric IgE regulates FcepsilonRI levels and cell survival in primary human basophils. Cell Death Dis. 2018;9(5):510.","journal-title":"Cell Death Dis"},{"issue":"6","key":"1062_CR20","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.4049\/jimmunol.1200968","volume":"189","author":"L Cassard","year":"2012","unstructured":"Cassard L, Jonsson F, Arnaud S, Da\u00ebron M. Fcgamma receptors inhibit mouse and human basophil activation. J Immunol. 2012;189(6):2995\u20133006.","journal-title":"J Immunol"},{"issue":"1\u20132","key":"1062_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.imlet.2009.12.001","volume":"130","author":"CT Cady","year":"2010","unstructured":"Cady CT, Powell MS, Harbeck RJ, Giclas PC, Murphy JR, Katial RK, et al. IgG antibodies produced during subcutaneous allergen immunotherapy mediate inhibition of basophil activation via a mechanism involving both FcgammaRIIA and FcgammaRIIB. Immunol Lett. 2010;130(1\u20132):57\u201365.","journal-title":"Immunol Lett"},{"issue":"1","key":"1062_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.18176\/jiaci.1072","volume":"36","author":"S Blank","year":"2026","unstructured":"Blank S, Dorn B, Seiringer P, Grosch J, Slusarenko BO, Dittmar M, et al. Component-resolved IgE and IgG4 profiling reveals robust IgG4 responses primarily to abundant Hymenoptera allergens during venom immunotherapy and in beekeepers. J Investig Allergol Clin Immunol. 2026;36(1):25\u201335.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"2","key":"1062_CR23","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1159\/000094714","volume":"141","author":"RJ van Neerven","year":"2006","unstructured":"van Neerven RJ, Knol EF, Ejrnaes A, Wurtzen PA. IgE-mediated allergen presentation and blocking antibodies: regulation of T-cell activation in allergy. Int Arch Allergy Immunol. 2006;141(2):119\u201329.","journal-title":"Int Arch Allergy Immunol"},{"issue":"3","key":"1062_CR24","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1365-2222.2006.02442.x","volume":"36","author":"AM Ejrnaes","year":"2006","unstructured":"Ejrnaes AM, Svenson M, Lund G, Larsen JN, Jacobi H. Inhibition of rBet v 1-induced basophil histamine release with specific immunotherapy -induced serum immunoglobulin G: no evidence that FcgammaRIIB signalling is important. Clin Exp Allergy. 2006;36(3):273\u201382.","journal-title":"Clin Exp Allergy"}],"container-title":["Allergy, Asthma &amp; Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13223-026-01062-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-026-01062-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-026-01062-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:10:17Z","timestamp":1791238217000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13223-026-01062-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1062"],"URL":"https:\/\/doi.org\/10.1186\/s13223-026-01062-w","relation":{},"ISSN":["1710-1492"],"issn-type":[{"value":"1710-1492","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"assertion":[{"value":"14 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Medical Ethics Committee of the Julius-Maximilians-University W\u00fcrzburg, Germany (reference number 255\/13) and written informed consent was obtained from all participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"54"}}